There is no product that matches the search criteria.
Your cart is empty.
4-HO-MET AKA schleeb, colour, methylcybin, metocin, and officially known by the name 4-Hydroxy-N-methyl-N-ethyltryptamine, is a lesser-known psychedelic of the tryptamine class. The American scientist documented his discovery in 1997 in his book TiHKAL "Tryptamines I Have Known and Loved". The appearance on the online research chemicals market began later after the year 2000 and appeared alongside other psilocybin structurally like substances such as 4-HO-MiPT and 4-AcO-DMT.
The psychedelic research results of 4-HO-MET are believed to stem from its activity on the 5-HT2A receptor as a partial agonist. However, this role and how they result in these research results remains the subject of ongoing scientific research. Opportunity for researchers to investigate this further!
Ensure to store the 4-HO-MET Spray Bottles in a dry and cool place for maximum shelf-life. When handling research chemicals ensure to always take the proper precautions in the laboratory like wiping down surfaces and wearing gloves, a mask & protective clothing. We strongly advised using harm reduction practices when using research chemicals.
The definition of 4-HO-MET is officially known as 4-Hydroxy-N-methyl-N-ethyltryptamine. Schleeb, colour, methylcybin, metocin are all common names that are used for this lesser-known psychedelic of the tryptamine class. 4-HO-MET is structurally related to psilocin also known as the magic mushroom.
4-HO-MET, or 4-hydroxy-N-ethyl-N-methyltryptamine, is a synthetic molecule of the tryptamine class. Tryptamines share a core structure consisting of a bicyclic indole heterocycle linked at R3 to an amino group via an ethyl side chain. 4-hydroxy-N-ethyl-N-methyltryptamine also contains a methyl group and an ethyl chain bonded to the terminal amine RN of its tryptamine backbone (MET).
4-HO-MET is related to 4-AcO-MET and psilocin (4-HO-DMT). It is also the 4-hydroxyl analog of the base tryptamine MET. The psychedelic outcomes are believed to derive from its activity on the 5-HT2A receptor as a partial agonist. However, the role of these outcomes and how they result remains the subject of ongoing scientific research.
English